Fonar Corporation (FONR): Price and Financial Metrics

Fonar Corporation (FONR)

Today's Latest Price: $14.40 USD

0.26 (1.84%)

Updated Mar 27 12:00am

Add FONR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

FONR Stock Summary

  • With a one year PEG ratio of 255.78, Fonar Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 88.71% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.27 for Fonar Corp; that's greater than it is for merely 14.77% of US stocks.
  • With a year-over-year growth in debt of 8,706.08%, Fonar Corp's debt growth rate surpasses 99.32% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fonar Corp are MGIC, TANH, MLHR, UUU, and GIGM.
  • Visit FONR's SEC page to see the company's official filings. To visit the company's web site, go to
FONR Daily Price Range
FONR 52-Week Price Range

FONR Stock Price Chart More Charts

FONR Price/Volume Stats

Current price $14.40 52-week high $25.25
Prev. close $14.14 52-week low $11.00
Day low $13.64 Volume 22,900
Day high $14.43 Avg. volume 33,077
50-day MA $18.33 Dividend yield N/A
200-day MA $20.63 Market Cap 92.85M

Fonar Corporation (FONR) Company Bio

Fonar Corporation engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. It operates in two segments, Medical Equipment, and Physician and Diagnostic Services Management. The company was founded in 1978 and is based in Melville, New York.

FONR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Fonar Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Fonar Corp ranked in the 62th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 117%. The most interesting components of our discounted cash flow analysis for Fonar Corp ended up being:

  • The company has produced more trailing twelve month cash flow than only 23.14% of its sector Healthcare.
  • Fonar Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than only 23.65% of tickers in our DCF set.
  • FONR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than only 23.65% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as FONR, try PDEX, DYNT, AMN, IONS, and MEDP.

FONR Latest News Stream

Event/TimeNews Detail
Loading, please wait...

FONR Latest Social Stream

Loading social stream, please wait...

View Full FONR Social Stream

FONR Price Returns

1-mo -27.93%
3-mo -25.12%
6-mo -28.57%
1-year -29.65%
3-year -18.18%
5-year 10.43%
YTD -26.87%
2019 -2.72%
2018 -16.88%
2017 27.15%
2016 10.95%
2015 65.96%

Continue Researching FONR

Want to see what other sources are saying about Fonar Corp's financials and stock price? Try the links below:

Fonar Corp (FONR) Stock Price | Nasdaq
Fonar Corp (FONR) Stock Quote, History and News - Yahoo Finance
Fonar Corp (FONR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7241 seconds.